Skip to main content
Top
Published in: Abdominal Radiology 7/2019

01-07-2019 | Sectio Ceasarea | Pelvis

Placenta accreta spectrum: value of placental bulge as a sign of myometrial invasion on MR imaging

Authors: Priyanka Jha, Joseph Rabban, Lee-may Chen, Ruth B. Goldstein, Stefanie Weinstein, Tara A. Morgan, Dorothy Shum, Nancy Hills, Michael A. Ohliger, Liina Poder

Published in: Abdominal Radiology | Issue 7/2019

Login to get access

Abstract

Purpose

To evaluate correlation of “placental bulge sign” with myometrial invasion in placenta accreta spectrum (PAS) disorders. Placental bulge is defined as deviation of external uterine contour from expected plane caused by abnormal outward bulge of placental tissue.

Materials and methods

In this IRB-approved, retrospective study, all patients undergoing MRI for PAS disorders between March 2014 and 2018 were included. Patients who delivered elsewhere were excluded. Imaging was reviewed by 2 independent readers. Surgical pathology from Cesarean hysterectomy or pathology of the delivered placenta was used as reference standard. Fisher’s exact and kappa tests were used for statistical analysis.

Results

Sixty-one patients underwent MRI for PAS disorders. Two excluded patients delivered elsewhere. Placental bulge was present in 32 of 34 cases with myometrial invasion [True positive 32/34 = 94% (95% CI 0.80–0.99)]. Placental bulge was absent in 24 of 25 cases of normal placenta or placenta accreta without myometrial invasion [True negative = 24/25, 96% (95% CI 80–99.8%)]. Positive and negative predictive values were 97% and 96%, respectively. Placental bulge in conjunction with other findings of PAS disorder was 100% indicative of myometrial invasion (p < 0.01). Kappa value of 0.87 signified excellent inter-reader concordance. In 1 false positive, placenta itself was normal but the bulge was present. Surgical pathology revealed markedly thinned, fibrotic myometrium without accreta. One false-negative case was imaged at 16 weeks and may have been imaged too early.

Conclusions

Placental bulge in conjunction with other findings of invasive placenta is 100% predictive of myometrial invasion. Using the bulge alone without other signs can lead to false-positive results.
Literature
1.
go back to reference Jauniaux E, et al. (2018) FIGO consensus guidelines on placenta accreta spectrum disorders: Epidemiology. Int J Gynaecol Obstet 140(3):265–273CrossRef Jauniaux E, et al. (2018) FIGO consensus guidelines on placenta accreta spectrum disorders: Epidemiology. Int J Gynaecol Obstet 140(3):265–273CrossRef
2.
go back to reference Jauniaux E, Collins S, Burton GJ (2018) Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. Am J Obstet Gynecol 218(1):75–87CrossRef Jauniaux E, Collins S, Burton GJ (2018) Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. Am J Obstet Gynecol 218(1):75–87CrossRef
3.
go back to reference Solheim KN, et al. (2011) The effect of cesarean delivery rates on the future incidence of placenta previa, placenta accreta, and maternal mortality. J Matern Fetal Neonatal Med 24(11):1341–1346CrossRefPubMed Solheim KN, et al. (2011) The effect of cesarean delivery rates on the future incidence of placenta previa, placenta accreta, and maternal mortality. J Matern Fetal Neonatal Med 24(11):1341–1346CrossRefPubMed
4.
go back to reference Fitzpatrick, K.E., et al., The management and outcomes of placenta accreta, increta, and percreta in the UK: a population-based descriptive study. BJOG, 2014. 121(1): p. 62-70; discussion 70-1. Fitzpatrick, K.E., et al., The management and outcomes of placenta accreta, increta, and percreta in the UK: a population-based descriptive study. BJOG, 2014. 121(1): p. 62-70; discussion 70-1.
5.
go back to reference Thurn L, et al. (2016) Abnormally invasive placenta-prevalence, risk factors and antenatal suspicion: results from a large population-based pregnancy cohort study in the Nordic countries. BJOG 123(8):1348–1355CrossRefPubMed Thurn L, et al. (2016) Abnormally invasive placenta-prevalence, risk factors and antenatal suspicion: results from a large population-based pregnancy cohort study in the Nordic countries. BJOG 123(8):1348–1355CrossRefPubMed
6.
go back to reference Miller DA, Chollet JA, Goodwin TM (1997) Clinical risk factors for placenta previa-placenta accreta. Am J Obstet Gynecol 177(1):210–214CrossRefPubMed Miller DA, Chollet JA, Goodwin TM (1997) Clinical risk factors for placenta previa-placenta accreta. Am J Obstet Gynecol 177(1):210–214CrossRefPubMed
7.
go back to reference Allen L, et al. (2018) FIGO consensus guidelines on placenta accreta spectrum disorders: Nonconservative surgical management. Int J Gynaecol Obstet 140(3):281–290CrossRef Allen L, et al. (2018) FIGO consensus guidelines on placenta accreta spectrum disorders: Nonconservative surgical management. Int J Gynaecol Obstet 140(3):281–290CrossRef
8.
go back to reference Creanga, A.A., et al., Morbidity associated with cesarean delivery in the United States: is placenta accreta an increasingly important contributor? Am J Obstet Gynecol, 2015. 213(3): p. 384 e1-11. Creanga, A.A., et al., Morbidity associated with cesarean delivery in the United States: is placenta accreta an increasingly important contributor? Am J Obstet Gynecol, 2015. 213(3): p. 384 e1-11.
9.
go back to reference Chantraine F, et al. (2012) Individual decisions in placenta increta and percreta: a case series. J Perinat Med 40(3):265–270CrossRefPubMed Chantraine F, et al. (2012) Individual decisions in placenta increta and percreta: a case series. J Perinat Med 40(3):265–270CrossRefPubMed
10.
go back to reference Brookfield KF, et al. (2014) Perioperative and transfusion outcomes in women undergoing cesarean hysterectomy for abnormal placentation. Transfusion 54(6):1530–1536CrossRefPubMed Brookfield KF, et al. (2014) Perioperative and transfusion outcomes in women undergoing cesarean hysterectomy for abnormal placentation. Transfusion 54(6):1530–1536CrossRefPubMed
11.
go back to reference Grace Tan SE, et al. (2013) Surgical management of placenta accreta: a 10-year experience. Acta Obstet Gynecol Scand 92(4):445–450CrossRefPubMed Grace Tan SE, et al. (2013) Surgical management of placenta accreta: a 10-year experience. Acta Obstet Gynecol Scand 92(4):445–450CrossRefPubMed
12.
go back to reference Woldu SL, et al. (2014) Urologic considerations of placenta accreta: a contemporary tertiary care institutional experience. Urol Int 93(1):74–79CrossRefPubMed Woldu SL, et al. (2014) Urologic considerations of placenta accreta: a contemporary tertiary care institutional experience. Urol Int 93(1):74–79CrossRefPubMed
13.
go back to reference Jauniaux E, Bhide A (2017) Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: a systematic review and meta-analysis. Am J Obstet Gynecol 217(1):27–36CrossRefPubMed Jauniaux E, Bhide A (2017) Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: a systematic review and meta-analysis. Am J Obstet Gynecol 217(1):27–36CrossRefPubMed
14.
go back to reference Jauniaux E, et al. (2018) FIGO consensus guidelines on placenta accreta spectrum disorders: Introduction. Int J Gynaecol Obstet 140(3):261–264CrossRef Jauniaux E, et al. (2018) FIGO consensus guidelines on placenta accreta spectrum disorders: Introduction. Int J Gynaecol Obstet 140(3):261–264CrossRef
15.
go back to reference Jauniaux E, et al. (2018) FIGO consensus guidelines on placenta accreta spectrum disorders: Prenatal diagnosis and screening. Int J Gynaecol Obstet 140(3):274–280CrossRef Jauniaux E, et al. (2018) FIGO consensus guidelines on placenta accreta spectrum disorders: Prenatal diagnosis and screening. Int J Gynaecol Obstet 140(3):274–280CrossRef
16.
go back to reference D’Antonio F, Iacovella C, Bhide A (2013) Prenatal identification of invasive placentation using ultrasound: systematic review and meta-analysis. Ultrasound Obstet Gynecol 42(5):509–517CrossRefPubMed D’Antonio F, Iacovella C, Bhide A (2013) Prenatal identification of invasive placentation using ultrasound: systematic review and meta-analysis. Ultrasound Obstet Gynecol 42(5):509–517CrossRefPubMed
17.
go back to reference Budorick NE, et al. (2017) Another look at ultrasound and magnetic resonance imaging for diagnosis of placenta accreta. J Matern Fetal Neonatal Med 30(20):2422–2427CrossRefPubMed Budorick NE, et al. (2017) Another look at ultrasound and magnetic resonance imaging for diagnosis of placenta accreta. J Matern Fetal Neonatal Med 30(20):2422–2427CrossRefPubMed
18.
go back to reference D’Antonio F, et al. (2014) Prenatal identification of invasive placentation using magnetic resonance imaging: systematic review and meta-analysis. Ultrasound Obstet Gynecol 44(1):8–16CrossRefPubMed D’Antonio F, et al. (2014) Prenatal identification of invasive placentation using magnetic resonance imaging: systematic review and meta-analysis. Ultrasound Obstet Gynecol 44(1):8–16CrossRefPubMed
19.
go back to reference McLean LA, et al. (2011) Assessing the role of magnetic resonance imaging in the management of gravid patients at risk for placenta accreta. Acad Radiol 18(9):1175–1180CrossRefPubMed McLean LA, et al. (2011) Assessing the role of magnetic resonance imaging in the management of gravid patients at risk for placenta accreta. Acad Radiol 18(9):1175–1180CrossRefPubMed
20.
go back to reference Meng X, Xie L, Song W (2013) Comparing the diagnostic value of ultrasound and magnetic resonance imaging for placenta accreta: a systematic review and meta-analysis. Ultrasound Med Biol 39(11):1958–1965CrossRefPubMed Meng X, Xie L, Song W (2013) Comparing the diagnostic value of ultrasound and magnetic resonance imaging for placenta accreta: a systematic review and meta-analysis. Ultrasound Med Biol 39(11):1958–1965CrossRefPubMed
21.
go back to reference Palacios-Jaraquemada JM, Bruno CH, Martin E (2013) MRI in the diagnosis and surgical management of abnormal placentation. Acta Obstet Gynecol Scand 92(4):392–397CrossRefPubMed Palacios-Jaraquemada JM, Bruno CH, Martin E (2013) MRI in the diagnosis and surgical management of abnormal placentation. Acta Obstet Gynecol Scand 92(4):392–397CrossRefPubMed
22.
go back to reference Ueno Y, et al. (2014) Novel MRI finding for diagnosis of invasive placenta praevia: evaluation of findings for 65 patients using clinical and histopathological correlations. Eur Radiol 24(4):881–888CrossRef Ueno Y, et al. (2014) Novel MRI finding for diagnosis of invasive placenta praevia: evaluation of findings for 65 patients using clinical and histopathological correlations. Eur Radiol 24(4):881–888CrossRef
23.
go back to reference Bourgioti C, et al. (2018) MRI Features Predictive of Invasive Placenta With Extrauterine Spread in High-Risk Gravid Patients: A Prospective Evaluation. AJR Am J Roentgenol 211(3):701–711CrossRefPubMed Bourgioti C, et al. (2018) MRI Features Predictive of Invasive Placenta With Extrauterine Spread in High-Risk Gravid Patients: A Prospective Evaluation. AJR Am J Roentgenol 211(3):701–711CrossRefPubMed
24.
go back to reference Chen, X., et al., Invasive placenta previa: Placental bulge with distorted uterine outline and uterine serosal hypervascularity at 1.5T MRI - useful features for differentiating placenta percreta from placenta accreta. Eur Radiol, 2018. 28(2): p. 708–717. Chen, X., et al., Invasive placenta previa: Placental bulge with distorted uterine outline and uterine serosal hypervascularity at 1.5T MRI - useful features for differentiating placenta percreta from placenta accreta. Eur Radiol, 2018. 28(2): p. 708–717.
25.
go back to reference Sentilhes L, et al. (2018) FIGO consensus guidelines on placenta accreta spectrum disorders: Conservative management. Int J Gynaecol Obstet 140(3):291–298CrossRef Sentilhes L, et al. (2018) FIGO consensus guidelines on placenta accreta spectrum disorders: Conservative management. Int J Gynaecol Obstet 140(3):291–298CrossRef
26.
go back to reference Chantraine F, et al. (2013) Prenatal diagnosis of abnormally invasive placenta reduces maternal peripartum hemorrhage and morbidity. Acta Obstet Gynecol Scand 92(4):439–444CrossRefPubMed Chantraine F, et al. (2013) Prenatal diagnosis of abnormally invasive placenta reduces maternal peripartum hemorrhage and morbidity. Acta Obstet Gynecol Scand 92(4):439–444CrossRefPubMed
27.
go back to reference Eller AG, et al. (2011) Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care. Obstet Gynecol 117(2 Pt 1):331–337CrossRefPubMed Eller AG, et al. (2011) Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care. Obstet Gynecol 117(2 Pt 1):331–337CrossRefPubMed
28.
go back to reference Shamshirsaz, A.A., et al., Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. Am J Obstet Gynecol, 2015. 212(2): p. 218 e1-9. Shamshirsaz, A.A., et al., Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. Am J Obstet Gynecol, 2015. 212(2): p. 218 e1-9.
29.
go back to reference Silver RM, et al. (2015) Center of excellence for placenta accreta. Am J Obstet Gynecol 212(5):561–568CrossRefPubMed Silver RM, et al. (2015) Center of excellence for placenta accreta. Am J Obstet Gynecol 212(5):561–568CrossRefPubMed
30.
go back to reference Pettit, K.E., et al., Maternal and neonatal outcomes among scheduled versus unscheduled deliveries in women with prenatally diagnosed, pathologically proven placenta accreta. J Matern Fetal Neonatal Med, 2017: p. 1–5. Pettit, K.E., et al., Maternal and neonatal outcomes among scheduled versus unscheduled deliveries in women with prenatally diagnosed, pathologically proven placenta accreta. J Matern Fetal Neonatal Med, 2017: p. 1–5.
31.
go back to reference Jauniaux E, et al. (2016) Accreta placentation: a systematic review of prenatal ultrasound imaging and grading of villous invasiveness. Am J Obstet Gynecol 215(6):712–721CrossRefPubMed Jauniaux E, et al. (2016) Accreta placentation: a systematic review of prenatal ultrasound imaging and grading of villous invasiveness. Am J Obstet Gynecol 215(6):712–721CrossRefPubMed
32.
go back to reference Rac, M.W., et al., Ultrasound predictors of placental invasion: the Placenta Accreta Index. Am J Obstet Gynecol, 2015. 212(3): p. 343 e1-7. Rac, M.W., et al., Ultrasound predictors of placental invasion: the Placenta Accreta Index. Am J Obstet Gynecol, 2015. 212(3): p. 343 e1-7.
33.
go back to reference Weiniger CF, et al. (2013) Outcomes of prospectively-collected consecutive cases of antenatal-suspected placenta accreta. Int J Obstet Anesth 22(4):273–279CrossRefPubMed Weiniger CF, et al. (2013) Outcomes of prospectively-collected consecutive cases of antenatal-suspected placenta accreta. Int J Obstet Anesth 22(4):273–279CrossRefPubMed
34.
go back to reference Matsuo K, Conturie CL, Lee RH (2014) Snowman sign: a possible predictor of catastrophic abnormal placentation. Eur J Obstet Gynecol Reprod Biol 181:341–342CrossRefPubMed Matsuo K, Conturie CL, Lee RH (2014) Snowman sign: a possible predictor of catastrophic abnormal placentation. Eur J Obstet Gynecol Reprod Biol 181:341–342CrossRefPubMed
35.
go back to reference Horowitz JM, et al. (2015) When Timing Is Everything: Are Placental MRI Examinations Performed Before 24 Weeks’ Gestational Age Reliable? AJR Am J Roentgenol 205(3):685–692CrossRefPubMed Horowitz JM, et al. (2015) When Timing Is Everything: Are Placental MRI Examinations Performed Before 24 Weeks’ Gestational Age Reliable? AJR Am J Roentgenol 205(3):685–692CrossRefPubMed
Metadata
Title
Placenta accreta spectrum: value of placental bulge as a sign of myometrial invasion on MR imaging
Authors
Priyanka Jha
Joseph Rabban
Lee-may Chen
Ruth B. Goldstein
Stefanie Weinstein
Tara A. Morgan
Dorothy Shum
Nancy Hills
Michael A. Ohliger
Liina Poder
Publication date
01-07-2019
Publisher
Springer US
Published in
Abdominal Radiology / Issue 7/2019
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-019-02008-0

Other articles of this Issue 7/2019

Abdominal Radiology 7/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.